#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4805273	B	Inhibition of recombinant human STK19 at 10 uM using HA-tagged GTP-preloaded NRAS as substrate incubated for 0-40 mins and measured by ADP-Glo assay relative to control	Homo sapiens	46	ALA4804283	single protein format	Patent Bioactivity Data
2.	ALA4805274	B	Inhibition of recombinant human STK19 using HA-tagged GTP-preloaded NRAS as substrate incubated for 0-40 mins and measured by ADP-Glo assay	Homo sapiens	17	ALA4804283	single protein format	Patent Bioactivity Data
3.	ALA4805275	B	Inhibition of recombinant human STK19 assessed as NRAS phosphorylation in presence of 10 uM ATP	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
4.	ALA4805276	B	Inhibition of recombinant human STK19 assessed as NRAS phosphorylation in presence of 30 uM ATP	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
5.	ALA4805277	B	Inhibition of recombinant human STK19 assessed as NRAS phosphorylation in presence of 100 uM ATP	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
6.	ALA4805278	B	Inhibition of recombinant human STK19 assessed as NRAS phosphorylation in presence of 300 uM ATP	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
7.	ALA4805280	B	Inhibition of recombinant human STK19 assessed as NRAS phosphorylation at 1-3 uM relative to control	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
8.	ALA4805281	B	Binding affinity to recombinant human STK19 assessed as change in melting temperature	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
9.	ALA4805282	B	Inhibition of wild-type STK19 (unknown origin) by biochemical assay	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
10.	ALA4805283	B	Inhibition of STK19 V134Y mutant (unknown origin) by biochemical assay	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
11.	ALA4805284	B	Inhibition of STK19 L139F mutant (unknown origin) by biochemical assay	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
12.	ALA4805285	B	Inhibition of STK19 D89N mutant (unknown origin) by biochemical assay	Homo sapiens	1	ALA4804283	single protein format	Patent Bioactivity Data
13.	ALA4805286	B	Inhibition of wild-type STK19 in human primary melanocytes at 0.1-3 uM relative to control	Homo sapiens	1	ALA4804283	cell-based format	Patent Bioactivity Data
14.	ALA4805287	B	Inhibition of STK19 D89N mutant in human primary melanocytes at 0.1-3 uM relative to control	Homo sapiens	1	ALA4804283	cell-based format	Patent Bioactivity Data
15.	ALA4805317	B	Inhibition of STK19 in STK19-depleted human primary melanocytes expressing wild-type STK19 at 1-3 uM assessed as NRAS phosphorylation relative to control	Homo sapiens	1	ALA4804283	tissue-based format	Patent Bioactivity Data
16.	ALA4805318	B	Inhibition of STK19 in STK19-depleted human primary melanocytes expressing STK19 D89N mutant at 1-3 uM assessed as NRAS phosphorylation relative to control	Homo sapiens	1	ALA4804283	tissue-based format	Patent Bioactivity Data
17.	ALA4805323	B	Inhibition of STK19 in human SK-MEL-2 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as NRAS signaling relative to control	Homo sapiens	1	ALA4804283	cell-based format	Patent Bioactivity Data
18.	ALA4805324	B	Inhibition of STK19 in human WM2032 cells expressing NRAS Q61R and wild-type BRAF at 1-3 uM assessed as NRAS signaling relative to control	Homo sapiens	1	ALA4804283	cell-based format	Patent Bioactivity Data
19.	ALA4805325	B	Inhibition of STK19 in human A375 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as NRAS signaling relative to control	Homo sapiens	1	ALA4804283	cell-based format	Patent Bioactivity Data
20.	ALA4805326	B	Inhibition of STK19 in human UACC62 cells expressing wild-type NRAS and BRAF V600E mutant at 1-3 uM assessed as NRAS signaling relative to control	Homo sapiens	1	ALA4804283	cell-based format	Patent Bioactivity Data